RAD51 and cholangiocarcinoma: We further analyzed the prognostic value of RAD51in CCAs in the TCGA-CCA cohort and found high level of RAD51 still showed no significant influence on overall survival (p = 0.16) disease-free survival (0.085) (Fig. S5E-F).